LITTLE KNOWN FACTS ABOUT AML WALLET RISK CHECK.

Irrespective of achieving a complete response with exceptional induction therapy, negligible residual condition often persists, necessitating consolidation therapy to mitigate the risk of relapse by eradicating residual sickness. In people who've been given seven+3 induction therapy, consolidation therapy is initiated with high-dose cytarabine, al